Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Palisade Bio (PALI) Other Non Operating Income (2016 - 2025)

Historic Other Non Operating Income for Palisade Bio (PALI) over the last 15 years, with Q3 2025 value amounting to $59000.0.

  • Palisade Bio's Other Non Operating Income fell 4732.14% to $59000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $242000.0, marking a year-over-year decrease of 5820.38%. This contributed to the annual value of $433000.0 for FY2024, which is 4484.08% down from last year.
  • Palisade Bio's Other Non Operating Income amounted to $59000.0 in Q3 2025, which was down 4732.14% from $61000.0 recorded in Q2 2025.
  • In the past 5 years, Palisade Bio's Other Non Operating Income registered a high of $12.8 million during Q3 2021, and its lowest value of $41000.0 during Q4 2024.
  • Its 5-year average for Other Non Operating Income is $1.2 million, with a median of $188000.0 in 2023.
  • As far as peak fluctuations go, Palisade Bio's Other Non Operating Income surged by 127630000.0% in 2021, and later tumbled by 9666.25% in 2022.
  • Quarter analysis of 5 years shows Palisade Bio's Other Non Operating Income stood at $12.8 million in 2021, then tumbled by 98.97% to $131000.0 in 2022, then skyrocketed by 42.75% to $187000.0 in 2023, then crashed by 78.07% to $41000.0 in 2024, then soared by 43.9% to $59000.0 in 2025.
  • Its Other Non Operating Income stands at $59000.0 for Q3 2025, versus $61000.0 for Q2 2025 and $81000.0 for Q1 2025.